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Conclusions: In patients with recurrent GBM, CTV-Gd and 
CTV-T2 differed considerably from CTV-MPET. At least 5 mm 
margin to CTV-T2 would be necessary in the target volume 
delineation of recurrent GBM to cover CTV-MPET in the re-
irradiation planning. 
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Purpose/Objective: The aim of this study is to evaluate the 
reliability of MRI fusion for the determination of target 
volume when performing CT based intracranial stereotactic 
radiosurgery.  
Materials and Methods: Patients treated with CT based 
intracranial stereotactic radiosurgery with various diagnoses 
are included in the study. All patients were immobilized 
using stereotactic thermoplastic masks prior to simulation. 
The planning CT was obtained both with and without iv 
contrast with 1mm slice thickness. The images obtained were 
then fused with 3D, T1 weighted MR images with contrast by 
two different platforms (Eclipse 10.0, Velocity 3.0 rigid and 
Velocity 3.0 deformable). The target volume was contoured 
by the same physician in four different image sets (planning 
CT with iv contrast, planning CT fused with MRI by Eclipse 
software, planning CT fused with MRI with Velocity rigid 
fusion algorithm software, planning CT fused with MRI with 
Velocity deformable fusion algorithm software). The target 
volumes delineated on planning CT with iv contrast were 
determined as reference volume. The intersections of all 
volumes delineated with three different fusion algorithms 
were produced and ratios of the intersections were 
calculated. Values close to one was determined as the unit of 
similarity and were compared with Paired-Samples t test. The 
center of each target was determined and offsets were 
calculated according to the reference.  
Results: Eight intracranial targets were evaluated. All of the 
targets evaluated were clearly visualized in the planning CT 
with iv contast. Six of these lesions were metastases while 
the remaining two were meningioma. The median volume of 
the delineated targets on the planning CT with iv contrast 
was 9.53 cc. The intersecting volume with three different 
fusion algorithms (Eclipse fusion, Velocity rigid fusion and 
Velocity deformeable fusion) was 8.08, 6.74 and 6.84 cc 
respectively. The ratios of the intersections were 1.20, 1.42 
and 1.40 where all of these differences were significant 
(p=0.004, p=0.010 ve p=0.009). The maxiumum offset in each 
fusion was in Y axis and the most in velocity deformable 
fusion (mean 0.3 cm; 0.02-0.76cm). There was difference 
between offsets for the lesion which are close to or away 
from the bone. 
Conclusions: Determining the target volume with MRI fusion 
when performing CT based intracranial stereotactic 
radiosurgery may not be very reliable compared to obtaining 
a planning CT with iv contrast. Careful attention must be 
paid to this as this might affect not only the treatment 
outcomes but also the late toxicity.  
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Purpose/Objective: To analyse the survival after salvage 
radiosurgery and to identify the prognostic factors 
Materials and Methods: We retrospectively reviewed 87 
consecutive patients, with recurrent high-grade glioma, that 
underwent stereotactic radiosurgery between 1997 and 2010. 
We evaluated the survival after initial diagnosis and after re-
irradiation. The prognostic factors were analysed by bivariate 
and multivariate Cox regression model. 
Results: The median age was 48 years old. The primary 
histology included anaplastic astrocytoma (47%) and 
glioblastoma (53%). A margin dose of 18Gy was administered 
in the majority of cases (74%). The median survival after 
initial diagnosis was 21 months (39 months for anaplastic 
astrocytoma and 18.5 months for glioblastoma) and after re-
irradiation was 10 months (17 months for anaplastic 
astrocytoma and 7.5 months for glioblastoma). In the 
bivariate analyses the prognostic factors significantly 
associated with the survival after re-irradiation were: age, 
tumour and treatment volume at recurrence, recursive 
partitioning analyses classification, karnofsky performance 
score, histology, and margin to the planning target volume. 
Only the last four showed significant association in the 
multivariate analyses. 
Conclusions: stereotactic radiosurgery is a safe and may be 
an effective treatment option for selected patients diagnosed 
with recurrent high-grade glioma. The identified prognostic 
factors could help to individualise the treatment.  
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Purpose/Objective: Kaposi’s sarcoma (KS) is a low grade 
malignant vascular endothelial tumor which has a viral 
etiology; KS herpes virus (KSHV). It was found to be endemic 
in the Central and Southern Africa. Sporadic cases are found 
in the Mediterranean region. With the advent of HIV- AIDS 
epidemic, the incidence of Kaposi's sarcoma has increased. 
The Aim of the study is to determine the demographics of the 
disease, treatment and their outcomes. 
Materials and Methods: The study is a retrospective study of 
patients with Kaposi's sarcoma who presented to the unit 
from 2004-2013. It evaluated all histologically confirmed 
cases of KS for demographic information, HIV status, degree 
